Histamine receptors and cancer pharmacology

British Journal of Pharmacology

Volumn 161, Issue 4, 2010, Pages 755-767

  Medina, Vanina A ^a,b   Rivera, Elena S ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b National Scientific and Technical Research Council ^*  (Argentina)

Author keywords

anticancer drugs; breast cancer; cancer pharmacology; cell proliferation; colon cancer; histamine; histamine H 4 receptor; histamine H 4 receptor ligands; malignancy; melanoma

Indexed keywords

HISTAMINE; HISTAMINE H4 RECEPTOR; HISTAMINE RECEPTOR;

BREAST CANCER; CANCER GROWTH; CANCER RESEARCH; CELL PROLIFERATION; COLON CANCER; EXPERIMENTAL NEOPLASM; HISTAMINE METABOLISM; MELANOMA; PRIORITY JOURNAL; REVIEW;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL PROLIFERATION; DRUG DELIVERY SYSTEMS; DRUG DESIGN; HISTAMINE; HUMANS; NEOPLASMS; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, HISTAMINE;

EID: 77957230154     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2010.00961.x     Document Type: Review

References (116)

1. Adams WJ, Morris DL (1994). Short-course cimetidine and survival with colorectal cancer. Lancet 344 : 1768 1769.
2. Adams WJ, Lawson JA, Morris DL (1994). Cimetidine inhibits in vivo growth of human colon cancer and reverses histamine stimulated in vitro and in vivo growth. Gut 35 : 1632 1636.
3. Agarwala SS, Hellstrand K, Gehlsen K, Naredi P (2004). Immunotherapy with histamine and interleukin 2 in malignant melanoma with liver metastasis. Cancer Immunol Immunother 53 : 840 841. (Pubitemid 39149912)
4. Akdis CA, Simons FER (2006). Histamine receptors are hot in immunopharmacology. Eur J Pharmacol 533 : 69 76.
5. Bartholeyns J, Bouclier M (1984). Involvement of histamine in growth of mouse and rat tumors: antitumoral properties of monofluormethylhistidine, an enzyme-activated irreversible inhibitor of histidine decarbolxylase. Cancer Res 44 : 639 645. (Pubitemid 14187466)
6. Bartholeyns J, Fozard J (1985). Role of histamine in tumor development. Trends Pharmacol Sci 6 : 123 125.
7. Batra S, Fadeel I (1994). Release of intracellular calcium and stimulation of cell growth by ATP and histamine in human ovarian cancer cells (SKOV-3). Cancer Lett 77 : 57 63. (Pubitemid 24085250)
8. Boer K, Helinger E, Helinger A, Pocza P, Pos Z, Demeter P et al. (2008). Decreased expression of histamine H1 and H4 receptors suggests disturbance of local regulation in human colorectal tumours by histamine. Eur J Cell Biol 87 : 227 236.
9. Bolton E, King J, Morris DL (2000). H2-antagonists in the treatment of colon and breast cancer. Seminar Cancer Biol 10 : 3 10. (Pubitemid 30391950)
10. Bray F, McCarron P, Parkin DM (2004). The changing global patterns of female breast cancer incidence and mortality. Breast Cancer Res 6 : 229 239. (Pubitemid 39440251)
11. Camidge DR, Jodrell DI (2005). Chemotherapy. In : Knowles M, Selby P (eds). Introduction to the Cellular and Molecular Biology of Cancer. Oxford University Press :
12. Cashin RP, Lui P, Machado M, Hemels ME, Corey-Lisle PK, Einarson TR (2008). Advanced cutaneous malignant melanoma: a systematic review of economic and quality-of-life studies. Value Health 11 : 259 271. (Pubitemid 351473617)
13. Chanda R, Ganguly AK (1995). Diamine-oxidase activity and tissue di- and poly-amine contents of human ovarian, cervical and endometrial carcinoma. Cancer Lett 89 : 23 28.
14. Cianchi F, Cortesini C, Schiavone N, Perna F, Magnelli L, Fanti E et al. (2005). The role of cyclooxygenase-2 in mediating the effects of histamine on cell proliferation and vascular endothelial growth factor production in colorectal cancer. Clin Cancer Res 11 : 6807 6815. (Pubitemid 41428735)
15. Coge F, Guenin SP, Rique H, Boutin JA, Galizzi JP (2001). Structure and expression of the human histamine H4-receptor gene. Biochem Biophy Res Commun 284 : 301 309. (Pubitemid 32917975)
16. Connelly WM, Shenton FC, Lethbridge N, Leurs R, Waldvogel HJ, Faull RL et al. (2009). The histamine H4 receptor is functionally expressed on neurons in the mammalian CNS. Br J Pharmacol 157 : 55 63.
17. Cricco GP, Davio CA, Fitzsimons CP, Engel N, Bergoc RM, Rivera ES (1994). Histamine as an autocrine growth factor in experimental carcinomas. Agents Actions 43 : 17 20. (Pubitemid 24368177)
18. Cricco G, Martin G, Labombarda F, Cocca C, Bergoc R, Rivera E (2000). Human pancreatic carcinoma cell line Panc-I and the role of histamine on cell growth. Inflamm Res 49 (Suppl. 1 S68 S69. (Pubitemid 30262701)
19. Cricco GP, Martin GA, Medina VA, Núñez M, Gutiérrez AS, Cocca C et al. (2004). Histamine regulates the MAPK pathway via the H2 receptor in PANC-1 human cells. Inflamm Res 53 (Suppl. 1 S65 S66. (Pubitemid 38375689)
20. Cricco G, Martín G, Medina V, Núñez M, Mohamad N, Croci M et al. (2006). Histamine inhibits cell proliferation and modulates the expression of Bcl-2 family proteins via the H2 receptor in human pancreatic cancer cells. Anticancer Res 26 : 4443 4450. (Pubitemid 46031520)
21. Cricco GP, Mohamad NA, Sambuco LA, Genre F, Croci M, Gutiérrez AS et al. (2008). Histamine regulates pancreatic carcinoma cell growth through H3 and H4 receptors. Inflamm Res 57 (Suppl. 1 S23 S24.
22. Damaj BB, Barrena Becerra C, Esber HJ, Wen Y, Maghazachi AA (2007). Functional expression of H4 histamine receptor in human natural killer cells, monocytes, and dendritic cells. J Immunol 179 : 7907 7915.
23. Darvas Z, Sakurai E, Schwelberger HG, Hegyesi H, Rivera E, Othsu H et al. (2003). Autonomous histamine metabolism in human melanoma cells. Melanoma Res 13 : 239 246. (Pubitemid 36683765)
24. Davenas E, Rouleau A, Morisset S, Arrang JM (2008). Autoregulation of McA-RH7777 hepatoma cell proliferation by histamine H3 receptor. J Pharmacol Exp Ther 326 : 406 413.
25. Davio CA, Cricco GP, Andrade N, Bergoc RM, Rivera ES (1993). H1 and H2 histamine receptors in human mammary carcinomas. Agents Actions 38 : C172 C174.
26. Davio CA, Cricco GP, Martin G, Fitzsimons CP, Bergoc RM, Rivera ES (1994). Effect of histamine on growth and differentiation of the rat mammary gland. Agents Actions 41 : C115 C117. (Pubitemid 24199951)
27. Davio CA, Cricco GP, Bergoc RM, Rivera ES (1995). H1 and H2 histamine receptors in experimental carcinomas with an atypical coupling to signal transducers. Biochem Pharmacol 50 : 91 96.
28. Davio C, Madlovan A, Shayo C, Lemos B, Baldi A, Rivera E (1996). Histamine receptors in neoplastic transformation. Studies in human cell lines. Inflamm Res 45 (Suppl. 1 S62 S63. (Pubitemid 26097490)
29. Davio C, Mladovan A, Lemos B, Monczor F, Shayo C, Rivera E et al. (2002). H1 and H2 histamine receptors mediate the production of inositol phosphates but not cAMP in human breast epithelial cells. Inflamm Res 51 : 1 7. (Pubitemid 34117366)
30. De Esch JP, Thurmond RL, Jongejan A, Leurs R (2005). The histamine H4 receptor as a new therapeutic target for inflammation. Trends Pharmacol Sci 26 : 462 469. (Pubitemid 41207878)
31. Dy M, Schneider E (2004). Histamine-cytokine connection in immunity and hematopoiesis. Cytokine Growth Factor Rev 15 : 393 410. (Pubitemid 39140701)
32. Engel N, Cricco G, Davio C, Martin G, Croci M, Fitzsimons C et al. (1996). Histamine regulates the expression of histidine decarboxylase in NMU-induced tumors in rats. Inflamm Res 45 (Suppl. 1 S64 S65.
33. Falus A, Hegyesi H, Lazar-Molnar E, Pos Z, Laszlo V, Darvas Z (2001). Paracrine and autocrine interactions in melanoma: histamine is a relevant player in local regulation. Trends Immunol 22 : 648 652. (Pubitemid 34008594)
34. Fentiman IS (2005). Local treatment of cancer. In : Knowles M, Selby P (eds). Introduction to the Cellular and Molecular Biology of Cancer. Oxford University Press :
35. Fitzsimons C, Engel N, Policastro L, Durán H, Molinari B, Rivera E (2002). Regulation of phospholipase C activation by the number of H(2) receptors during Ca(2+)-induced differentiation of mouse keratinocytes. Biochem Pharmacol 63 : 1785 1796. (Pubitemid 34603443)
36. Frank LM, Knowles MA (2005). What is cancer? In : Knowles M, Selby P (eds). Introduction to the Cellular and Molecular Biology of Cancer. Oxford University Press :
37. Galmarini CM (2004). Histamine dihydrochloride (subcutaneous) Maxim. Curr Opin Investig Drugs 5 : 1298 1310.
38. Garcia-Caballero M, Neugebauer E, Campos R, Nunez de Castro I, Vara-Thorbeck C (1988). Increased histidine decarboxylase (HDC) activity in human colorectal cancer: results of a study on ten patients. Agents Actions 23 : 357 360.
39. Garcia-Caballero M, Neugebauer E, Campos R, Nuñez de Castro I, Vara-Thorbeck C (1994). Histamine synthesis and content in benign and malignant breast tumors. Surg Oncol 3 : 167 173.
40. Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN (2007). Overview of resistance to systemic therapy in patients with breast cancer. Adv Exp Med Biol 608 : 1 22.
41. Gray-Schopfer V, Wellbrock C, Marais R (2007). Melanoma biology and new targeted therapy. Nature 445 : 851 857. (Pubitemid 46309849)
42. Haak-Frendscho M, Darvas A, Hegyesi H, Karpati S, Hoffman R, Laszló V et al. (2000). Histidine decarboxylase expression in human melanoma. J Invest Dermatol 115 : 345 352.
43. Hall EJ, Giaccia AJ (2006). Cancer biology. In : Hall EJ, Giaccia AJ (eds). Radiobiology for the Radiologist. Lippincott Williams & Wilkins :
44. Hanahan D, Weinberg RA (2000). The hallmarks of cancer. Cell 100 : 57 70. (Pubitemid 30046295)
45. Hashimoto T, Harusawa S, Araki L, Zuiderveld OP, Smit MJ, Imazu T et al. (2003). A selective human H(4)-receptor agonist: (-)-2-cyano-1-methyl-3-[(2R,5R) -5- [1H-imidazol-4(5)-yl]tetrahydrofuran-2-y] methylguanidine. J Med Chem 46 : 3162 3165.
46. Hegyesi H, Somlai B, Varga VL, Toth G, Kovacs P, Mólnar EL et al. (2001). Suppression of melanoma cell proliferation by histidine decarboxylase specific antisense oligonucleotides. J Invest Dermatol 117 : 151 153. (Pubitemid 32652453)
47. Hegyesi H, Horváth B, Pállinger E, Pós Z, Molnár V, Falus A (2005). Histamine elevates the expression of Ets-1, a protooncogen in human melanoma cell lines through H2 receptor. FEBS Lett 579 : 2475 2479. (Pubitemid 40569524)
48. Hill SJ, Ganellin CR, Timmerman H, Schwartz JC, Shankley NP, Young JM et al. (1997). International Union of Pharmacology. XIII. Classification of histamine receptors. Pharmacol Rev 49 : 253 284. (Pubitemid 27414915)
49. Hofstra CL, Desai PJ, Thurmond RL, Fung-Leung WP (2003). Histamine H4 receptor mediates chemotaxis and calcium mobilization of mast cells. J Pharmacol Exp Ther 305 : 1212 1221.
50. Huang JF, Thurmond RL (2008). The new biology of histamine receptors. Curr Allergy Asthma Rep 8 : 21 27.
51. Jablonowski JA, Grice CA, Chai W, Dvorak CA, Venable JD, Kwok AK et al. (2003). The first potent and selective non-imidazole human histamine H4 receptor antagonists. J Med Chem 46 : 3957 3960. (Pubitemid 37122442)
52. Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun MJ (2003). Cancer statistics, 2003. CA Cancer J Clin 53 : 5 26. (Pubitemid 36163619)
53. Kahlson G, Rosengren E (1968). New approaches to the physiology of histamine. Physiol Rev 48 : 155 196.
54. Kapoor S, Pal S, Sahni P, Dattagupta S, Kanti Chattopadhyay T (2005). Effect of pre-operative short course famotidine on tumor infiltrating lymphocytes in colorectal cancer: a double blind, placebo controlled, prospective randomized study. J Surg Res 129 : 172 175. (Pubitemid 41797052)
55. Kelly MD, King J, Cherian M, Dwerryhouse SJ, Finlay IG, Adams WJ et al. (1999). Randomized trial of preoperative cimetidine in patients with colorectal carcinoma with quantitative assessment of tumor-associated lymphocytes. Cancer 85 : 1658 1663. (Pubitemid 29169664)
56. Kierska D, Fogel W, Malinski C (1997). Histamine concentration and metabolism in mouse mammary gland during estrous cycle. Inflamm Res 46 (Suppl. 1 S63 S64. (Pubitemid 27136276)
57. Koenig JR, Liu H, Drizin I, Witte DG, Carr TL, Manelli AM et al. (2010). Rigidified 2-aminopyrimidines as histamine H4 receptor antagonists: effects of substitution about the rigidifying ring. Bioorg Med Chem Lett 20 : 1900 1904.
58. Kuefner MA, Schwelberger HG, Hahn EG, Raithel M (2008). Decreased histamine catabolism in the colonic mucosa of patients with colonic adenoma. Dig Dis Sci 53 : 436 442. (Pubitemid 351170004)
59. Kyriakidis K, Zampeli E, Tiligada E (2009). Histamine levels in whole peripheral blood from women with ductal breast cancer: a pilot study. Inflamm Res 58 (Suppl. 1 S73 S74.
60. Lemos B, Davio C, Gass H, Gonzales P, Cricco G, Martín G et al. (1995). Histamine receptors in human mammary gland, different benign lesions and mammary carcinomas. Inflamm Res 44 (Suppl. 1 S68 S69.
61. Leurs R, Chazot PL, Shenton FC, Lim HD, de Esch IJ (2009). Molecular and biochemical pharmacology of the histamine H4 receptor. Br J Pharmacol 157 : 14 23.
62. Lim HD, van Rijn RM, Ling P, Bakker RA, Thurmond RL, Leurs R (2005). Evaluation of histamine H1-, H2-, and H3-receptor ligands at the human histamine H4 receptor: identification of 4-methylhistamine as the first potent and selective H4 receptor agonist. J Pharmacol Exp Ther 314 : 1310 1321.
63. Lim HD, Jongejan A, Bakker RA, Haaksma E, de Esch IJ, Leurs R (2008). Phenylalanine 169 in the second extracellular loop of the human histamine H4 receptor is responsible for the difference in agonist binding between human and mouse H4 receptors. J Pharmacol Exp Ther 327 : 88 96.
64. Lim HD, Adami M, Guaita E, Werfel T, Smits RA, de Esch IJ et al. (2009). Pharmacological characterization of the new histamine H4 receptor agonist VUF 8430. Br J Pharmacol 157 : 34 43.
65. Lim HD, de Graaf C, Jiang W, Sadek P, McGovern PM, Istyastono EP et al. (2010). Molecular determinants of ligand binding to H4R species variants. Mol Pharmacol 77 : 734 743.
66. Liu C, Ma XJ, Jiang X, Wilson SJ, Hofstra CL, Blevitt J et al. (2001a). Cloning and pharmacological characterization of a fourth histamine receptor (H4) expressed in bone marrow. Mol Pharmacol 59 : 420 426. (Pubitemid 32179918)
67. Liu C, Wilson SJ, Kuei C, Lovenberg TW (2001b). Comparison of human, mouse, rat, and guinea pig histamine H4 receptors reveals substantial pharmacological species variation. J Pharmacol Exp Ther 299 : 121 130. (Pubitemid 32905126)
68. Liu H, Altenbach RJ, Carr TL, Chandran P, Hsieh GC, Lewis LG et al. (2008). cis-4-(Piperazin-1-yl)-5,6,7a,8,9,10,11,11a-octahydrobenzofuro[2,3-h] quinazolin-2-amine (A-987306), a new histamine H4R antagonist that blocks pain responses against carrageenan-induced hyperalgesia. J Med Chem 51 : 7094 7098.
69. von Mach-Szczypiński J, Stanosz S, Sieja K, Stanosz M (2009). Metabolism of histamine in tissues of primary ductal breast cancer. Metabolism 58 : 867 870.
70. Malinski C, Kierska D, Fogel W, Kinnunum A, Panula P (1993). Histamine: its metabolism and localization in mammary gland. Comp Biochem Physiol C 105 : 269 273. (Pubitemid 23203998)
71. Markovic SN, Erickson LA, Rao RD, Weenig RH, Pockaj BA, Bardia A et al. (2007). Malignant melanoma in the 21st century, part 1: epidemiology, risk factors, screening, prevention, and diagnosis. Mayo Clin Proc 82 : 364 380. (Pubitemid 46348938)
72. Martín G, Cricco G, Darvas Z, Croci M, Núñez M, Bergoc R et al. (2002). Histamine inhibits proliferation of a pancreatic carcinoma cell line without inducing apoptosis significantly. Inflamm Res 51 (Suppl. 1 S67 S68. (Pubitemid 34299002)
73. Mathers CD, Loncar D (2006). Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 3 : e442. (Pubitemid 44875937)
74. Medina V, Cricco G, Nuñez M, Martín G, Mohamad N, Correa-Fiz F et al. (2006). Histamine-mediated signaling processes in human malignant mammary cells. Cancer Biol Ther 5 : 1462 1471. (Pubitemid 46256614)
75. Medina V, Croci M, Crescenti E, Mohamad N, Sanchez-Jiménez F, Massari N et al. (2008). The role of histamine in human mammary carcinogenesis: H3 and H4 receptors as potential therapeutic targets for breast cancer treatment. Cancer Biol Ther 7 : 28 35. (Pubitemid 351590448)
76. Medina VA, Massari NA, Cricco GP, Martín GA, Bergoc RM, Rivera ES (2009). Involvement of hydrogen peroxide in histamine-induced modulation of WM35 human malignant melanoma cell proliferation. Free Radic Biol Med 46 : 1510 1515.
77. Mitchell MS (2003). Immunotherapy as part of combinations for the treatment of cancer. Int Immunopharmacol 3 : 1051 1059. (Pubitemid 36830850)
78. Mitsuhashi M, Mitsuhashi T, Payan D (1989). Multiple signaling pathways of histamine H2 receptors. Identification of an H2 receptor-dependent Ca2+ mobilization pathway in human HL-60 promyelocytic leukemia cells. J Biol Chem 264 : 18356 18362. (Pubitemid 19277576)
79. Molnár EL, Cricco G, Martin G, Darvas Z, Hegyesi H, Fitzsimons C et al. (2001). Histamine as a potential autocrine regulator of melanoma. Inflamm Res 50 (Suppl. 1 S102 S103. (Pubitemid 32452988)
80. Molnár EL, Hegyesi H, Pállinger E, Kovács P, Tóth S, Fitzsimons C et al. (2002). Inhibition of human primary melanoma cell proliferation by histamine is enhanced by interleukin-6. Eur J Clin Invest 32 : 743 749. (Pubitemid 35334969)
81. Morse KL, Behan J, Laz TM, West RE Jr., Greenfeder SA, Anthes JC et al. (2001). Cloning and characterization of a novel human histamine receptor. J Pharmacol Exp Ther 296 : 1058 1066. (Pubitemid 32187382)
82. Nakamura T, Itadani H, Hidaka Y, Ohta M, Tanaka K (2000). Molecular cloning and characterization of a new human histamine receptor, HH4R. Biochem Biophys Res Commun 279 : 615 620. (Pubitemid 32016763)
83. Nguyen T, Shapiro DA, George SR, Setola V, Lee DK, Cheng R et al. (2001). Discovery of a novel member of the histamine receptor family. Mol Pharmacol 59 : 427 433. (Pubitemid 32179919)
84. Oda T, Morikawa N, Saito Y, Masuho Y, Matsumoto S (2000). Molecular cloning and characterization of a novel type of histamine receptor preferentially expressed in leukocytes. J Biol Chem 275 : 36781 36786. (Pubitemid 32002087)
85. Parkin DM, Bray F, Ferlay J, Pisani P (2005). Global cancer statistics, 2002. CA Cancer J Clin 55 : 74 108. (Pubitemid 40372904)
86. Parshad R, Hazrah P, Kumar S, Gupta SD, Ray R, Bal S (2005). Effect of preoperative short course famotidine on TILs and survival in breast cancer. Indian J Cancer 42 : 185 190. (Pubitemid 43479199)
87. Pós Z, Hegyesi H, Rivera ES (2004). Histamine and cell proliferation. In : Falus A (ed.). Histamine: Biology and Medical Aspects. SpringMed Publishing :
88. Pós Z, Sáfrány G, Müller K, Tóth S, Falus A, Hegyesi H (2005). Phenotypic profiling of engineered mouse melanomas with manipulated histamine production identifies histamine H2 receptor and Rho-c as histamine-regulated melanoma progression markers. Cancer Res 65 : 4458 4466. (Pubitemid 40775686)
89. Reynolds JL, Akhter J, Morris DL (1996). In vitro effect of histamine and histamine H1 and H2 receptor antagonists on cellular proliferation of human malignant melanoma cell lines. Melanoma Res 6 : 95 99. (Pubitemid 26259022)
90. Reynolds JL, Akhter J, Adams WJ, Morris DL (1997). Histamine content in colorectal cancer. Are there sufficient levels of histamine to affect lymphocyte function? Eur J Surg Oncol 23 : 224 227. (Pubitemid 27343152)
91. Reynolds JL, Akhter JA, Magarey CJ, Schwartz P, Adams WJ, Morris DL (1998). Histamine in human breast cancer. Br J Surg 85 : 538 541. (Pubitemid 28175454)
92. van Rijn RM, Chazot PL, Shenton FC, Sansuk K, Bakker RA, Leurs R (2006). Oligomerization of recombinant and endogenously expressed human histamine H(4) receptors. Mol Pharmacol 70 : 604 615. (Pubitemid 44092321)
93. van Rijn RM, van Marle A, Chazot PL, Langemeijer E, Qin Y, Shenton FC et al. (2008). Cloning and characterization of dominant negative splice variants of the human histamine H4 receptor. Biochem J 414 : 121 131.
94. Rivera E, Davio C, Cricco G, Bergoc R (1993). Histamine regulation of tumour growth. Role of H1 and H2 receptors. In : Garcia-Caballero M, Brandes L, Hosoda S (eds). Histamine in Normal and Cancer Cell Proliferation. Adv. in Bioscience, Pergamon Press :
95. Rivera ES, Cricco GP, Engel NI, Fitzimons CP, Martin GA, Bergoc RM (2000). Histamine as an autocrine growth factor: an unusual role for a widespread mediator. Semin Cancer Biol 10 : 15 23.
96. Siegers CP, Andresen S, Keogh JP (1999). Does cimetidine improve prospects for cancer patients? A reappraisal of the evidence to date. Digestion 60 : 415 421. (Pubitemid 29401769)
97. Sieja K, Stanosz S, Von Mach-Szczypinski J, Olewniezak S, Stanosz M (2005). Concentration of histamine in serum and tissues of the primary ductal breast cancer in women. Breast 14 : 236 241. (Pubitemid 40740437)
98. Smits RA, Leurs R, de Esch IJ (2009). Major advances in the development of histamine H4 receptor ligands. Drug Discov Today 14 : 745 753.
99. Smits RA, Adami M, Istyastono EP, Zuiderveld OP, van Dam CM, de Kanter FJ et al. (2010). Synthesis and QSAR of quinazoline sulfonamides as highly potent human histamine H4 receptor inverse agonists. J Med Chem 53 : 2390 2400.
100. Soule BP, Simone NL, DeGraff WG, Choudhuri R, Cook JA, Mitchell JB (2010). Loratadine dysregulates cell cycle progression and enhances the effect of radiation in human tumor cell lines. Radiat Oncol 5 : 8.
101. Strakhova MI, Cuff CA, Manelli AM, Carr TL, Witte DG, Baranowski JL et al. (2009). In vitro and in vivo characterization of A-940894: a potent histamine H4 receptor antagonist with anti-inflammatory properties. Br J Pharmacol 157 : 44 54.
102. Szincsák N, Hegyesi H, Hunyadi J, Falus A, Juhász I (2002a). Different h2 receptor antihistamines dissimilarly retard the growth of xenografted human melanoma cells in immunodeficient mice. Cell Biol Int 26 : 833 836. (Pubitemid 35266500)
103. Szincsák N, Hegyesi H, Hunyadi J, Martin G, Lázár- Molnár E, Kovács P et al. (2002b). Cimetidine and a tamoxifen derivate reduce tumour formation in SCID mice xenotransplanted with a human melanoma cell line. Melanoma Res 12 : 231 240. (Pubitemid 34666813)
104. Takahashi K, Tanaka S, Ichikawa A (2001). Effect of cimetidine on intratumoral cytokine expression in an experimental tumor. Biochem Biophys Res Commun 281 : 1113 1119. (Pubitemid 32924535)
105. Tanimoto A, Matsuki Y, Tomita T, Sasaguri T, Shimajiri S, Sasaguri Y (2004). Histidine decarboxylase expression in pancreatic endocrine cells and related tumors. Pathol Int 54 : 408 412. (Pubitemid 38829926)
106. Tiligada E, Zampeli E, Sander K, Stark H (2009). Histamine H3 and H4 receptors as novel drug targets. Expert Opin Investig Drugs 18 : 1519 1531.
107. Tilly BC, Tertoolen LGJ, Remorie R, Ladoux A, Verlaan I, De Laat SW et al. (1990). Histamine as a growth factor and chemoattractant for human carcinoma and melanoma cells: action through Ca2+-mobilizing H1 receptors. J Cell Biol 110 : 1211 1215. (Pubitemid 20136497)
108. Tomita K, Okabe S (2005). Exogenous histamine stimulates colorectal cancer implant growth via immunosuppression in mice. J Pharmacol Sci 97 : 116 123. (Pubitemid 40313107)
109. Tomita K, Izumi K, Okabe S (2003). Roxatidine- and cimetidine-induced angiogenesis inhibition suppresses growth of colon cancer implants in syngeneic mice. J Pharmacol Sci 93 : 321 330. (Pubitemid 37521354)
110. Tomita K, Nakamura E, Okabe S (2005). Histamine regulates growth of malignant melanoma implants via H2 receptors in mice. Inflammopharmacology 13 : 281 289. (Pubitemid 41607388)
111. Uar K (1991). The effects of histamine H2 receptor antagonists on melanogenesis and cellular proliferation in melanoma cells in culture. Biochem Biophys Res Commun 177 : 545 550.
112. Wagner W, Ichikawa A, Tanaka S, Panula P, Fogel WA (2003). Mouse mammary epithelial histamine system. J Physiol Pharm 54 : 211 223. (Pubitemid 36781475)
113. Wang LD, Hoeltzel M, Butler K, Hare B, Todisco A, Wang M et al. (1997). Activation of the human histamine H2 receptor is linked to cell proliferation and c-fos gene transcription. Am J Physiol 273 : C2037 C2045. (Pubitemid 28079548)
114. Wulff BS, Hastrup S, Rimvall K (2002). Characteristics of recombinantly expressed rat and human histamine H3 receptors. Eur J Pharmacol 453 : 33 41. (Pubitemid 35232452)
115. Zampeli E, Tiligada E (2009). The role of histamine H4 receptor in immune and inflammatory disorders. Br J Pharmacol 157 : 24 33.
116. Zhu Y, Michalovich D, Wu H, Tan KB, Dytko GM, Mannan IJ et al. (2001). Cloning, expression, and pharmacological characterization of a novel human histamine receptor. Mol Pharmacol 59 : 434 441. (Pubitemid 32179920)